GTBP Projected Dividend Yield
Com Par $0.001/GT Biopharma Inc ( NASDAQ : GTBP )GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. Its TriKE platform generates therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer (NK) cells. Co. is also using its TriKE platform to develop therapeutics useful for the treatment of infectious disease such as for the treatment of patients infected by the human immunodeficiency virus (HIV). 20 YEAR PERFORMANCE RESULTS |
GTBP Dividend History Detail GTBP Dividend News GTBP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |